We observed that GPX3, an extracellular antioxidant, was significantly upregulated in the high-risk group, which supports the extracellular antioxidant defense of ovarian cancer cells and contributes to the progression of ovarian cancer [52]. This evidence concerns the gene GPX3 and ovarian carcinoma.